InMed Pharmaceuticals Inc (NASDAQ:INM) shares are trading higher by 22.6% to $6.05 during Tuesday’s session after the company announced that INM-901 reduced Alzheimer’s-related inflammation in a ...
Reduces key pro-inflammatory markers, independent of amyloid beta or tau pathology Vancouver, British Columbia--(Newsfile Corp. - June 24, 2025) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or ...
Human Organoid Data Supports the Therapeutic Rationale for INM-901 Program Ahead of Human Clinical TrialsConsistent ...
View InMed Pharmaceuticals Inc. INM stock quote prices, financial information, real-time forecasts, and company news from CNN.
On Tuesday, InMed Pharmaceuticals Inc. (NASDAQ:INM) confirmed INM-901 as an oral formulation that will be utilized in its development programs for Alzheimer’s disease. Recent preclinical studies have ...
When it comes to treating degenerative diseases like Alzheimer’s, much of the current focus is on addressing the symptoms rather than repairing and regenerating the damaged tissues and cells. Some ...
InMed (NASDAQ: INM) stock rose 300% and change yesterday at one point. INM stock then fell back considerably on the announcement of a stock issue. Which is rather how this world of development pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results